Biontech to provide an update on manufacturing and development plans of mrna vaccines in africa

Mainz, germany, june 9, 2022 (globe newswire) —  biontech se (nasdaq: bntx, “biontech”) will welcome its african partners for the first time on the african continent and provide an update on the joint establishment of mrna manufacturing facilities and vaccine development plans. the event will encompass the groundbreaking for biontech's initial african mrna manufacturing facility in kigali, rwanda, where the first biontainer modules are planned to be delivered by the end of 2022.
BNTX Ratings Summary
BNTX Quant Ranking